Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:00 AM
Ignite Modification Date:
2025-12-25 @ 3:00 AM
NCT ID:
NCT01277133
Eligibility Criteria:
Inclusion Criteria:
* Adult patients, \>/=18 years of age
* Previously untreated metastatic breast cancer
* Scheduled to start 1st line chemotherapeutic treatment
* ECOG performance status 0-1
Exclusion Criteria:
* Any conditions included in contraindication list for Avastin
* Prior chemotherapy for metastatic breast cancer
* Adjuvant/neoadjuvant chemotherapy or radio-chemotherapy of non-metastatic malignancy completed \<6 months prior to treatment start
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01277133
Study Brief:
Protocol Section:
NCT01277133